Literature DB >> 3762317

Dihydropyridine calcium antagonists depress the amplitude of the plasma melatonin cycle in baboons.

A C Meyer, J J Nieuwenhuis, V J Kociszewska, W S Joubert, B J Meyer.   

Abstract

An investigation into the effects of verapamil and some dihydropyridine derivatives on plasma melatonin levels was undertaken in baboons. In a number of separate experiments, groups of young male chacma baboons (mean body weight 13 kg) received intraperitoneal injections of the drugs, under ketamine anaesthesia, roughly 30 minutes prior to the following time points: 1200, 1800, 0000, 0200, 0600 and 1200 h. Lights went off at 1800 h and came on at 0600 h. The drugs used, and their respective dosages (expressed per kg body mass), were verapamil up to 4 mg/kg, nifedipine at 0.2 mg/kg, nitrendipine at 0.5 mg/kg and nisoldipine at 0.1 mg/kg. Blood samples, taken at the said time points, were assayed for melatonin. The nighttime peak of the plasma melatonin cycle was significantly depressed by all three dihydropyridine calcium antagonists (up to 40%), while verapamil, even at the relatively high total dose of 24 mg/kg per day, had no significant effect on the circulating plasma melatonin levels.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3762317     DOI: 10.1016/0024-3205(86)90388-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Calcium channel drugs affect nocturnal serotonin N-acetyltransferase (NAT) activity in rat pineal gland.

Authors:  J B Zawilska; J Z Nowak
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  Newborn primate infants are entrained by low intensity lighting.

Authors:  S A Rivkees; P L Hofman; J Fortman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

Review 3.  Cellular and molecular mechanisms controlling melatonin release by mammalian pineal glands.

Authors:  D P Cardinali; M I Vacas
Journal:  Cell Mol Neurobiol       Date:  1987-12       Impact factor: 5.046

Review 4.  Melatonin: possible implications for the postoperative and critically ill patient.

Authors:  Richard S Bourne; Gary H Mills
Journal:  Intensive Care Med       Date:  2006-02-14       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.